On Wednesday, the penultimate day of the sale, Mankind Pharma's initial public offering was subscribed to 87%. Institutional investors subscribed 1.86 times, rich investors 1.02 times, and regular investors 25%. Mankind Pharma distributed Rs 1,298...
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the positive outcome of its arbitration with Tracon Pharmaceuticals (Tracon) relating to (1) the...
Nkure Therapeutics, an NK cell therapy startup, has announced the completion of its pre-Series A round, in which Endiya Partners, Kotak Investment Advisors, Featherlite, and a few angel investors participated. Nkure intends to use the funds to....
As India has the G20 presidency and South Korea is a member of the G20, the Korea Pharmaceuticals & Bio Manufacturers Association (KPBMA) in Seoul has inked a memorandum of understanding (MoU) with India. "The KPBMA has special significance,...
Sun Pharmaceutical Industries announced on Tuesday that it has launched a medication in the country to treat dry eye disease. The Mumbai-based pharmaceutical company announced the launch of Cequa, a novel ophthalmology treatment for patients....
Johnson & Johnson said on Monday that its consumer health unit, Kenvue, would seek a valuation of up to $42.95 billion in its initial public offering, at a time when investor appetite for new listings has been muted. The announcement sets the....
The IHW Council, India's premier think-tank for preventive and promotive health, has launched the Spirituality for Health & Environment Alliance (SHE-Alliance), which aims to empower women in society to take the lead on health transformation of ...
Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.The company has got the final approval from the US Food and Drug A...
Scott Smith, M.D., Ph.D. has been named senior vice president, global therapeutic area head - haematology at Parexel, one of the world's largest CROs providing a full range of phase I to IV clinical development services. Dr. Smith will be ...
Aptitude Medical Systems (Aptitude) announced a $53.7 million award from the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Administration for Strategic Preparedness and Response within the US Department...
, CDSCO.jpg)
